Not applicableStudy completedNCT00573833What this trial is testingInternal Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 23
Not applicableStudy completedNCT00897793What this trial is testingGrowth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+2 more Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00005847What this trial is testingChemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyWho this might be right forProstate Cancer Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00023686What this trial is testingSurgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT00329043What this trial is testingSunitinib Malate With Hormonal Ablation for Patients Who Will Have ProstatectomyWho this might be right forProstate Cancer M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Ended earlyNCT00040170What this trial is testingVaccine Study of MVA-MUC1-IL2 in Patients With Prostate CancerWho this might be right forProstatic Neoplasms Transgene 50
Testing effectiveness (Phase 2)Study completedNCT00242918What this trial is testingSafety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerWho this might be right forProstate Cancer Benaroya Research Institute 29
Testing effectiveness (Phase 2)Study completedNCT00005810What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Study completedNCT01270880What this trial is testingHsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyWho this might be right forAdenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more Barbara Ann Karmanos Cancer Institute 18
Testing effectiveness (Phase 2)WithdrawnNCT00771017What this trial is testingAndrogen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT02805894What this trial is testingNBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate AdenocarcinomaWho this might be right forProstate Cancer Nanobiotix 5
Not applicableStudy completedNCT00060086What this trial is testingPomegranate Juice in Treating Patients With Recurrent Prostate CancerWho this might be right forProstate Cancer Jonsson Comprehensive Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT01051570What this trial is testingCarboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After DocetaxelWho this might be right forProstate Cancer Barbara Ann Karmanos Cancer Institute 26
Testing effectiveness (Phase 2)WithdrawnNCT03147196What this trial is testingBicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWho this might be right forStage I Prostate AdenocarcinomaStage II Prostate Adenocarcinoma Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00005028What this trial is testingPaclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer University of Maryland, Baltimore 46
Testing effectiveness (Phase 2)Study completedNCT01882985What this trial is testingDocetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer PatientsWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more University of California, Irvine 14
Testing effectiveness (Phase 2)Looking for participantsNCT05806515What this trial is testingCarboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationWho this might be right forProstate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8 SWOG Cancer Research Network 44
Testing effectiveness (Phase 2)Study completedNCT02278185What this trial is testingEnzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate CancerWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage III Prostate Cancer+1 more University of Colorado, Denver 19
Testing effectiveness (Phase 2)WithdrawnNCT00003858What this trial is testingMitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for RecurrenceWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Ended earlyNCT04252625What this trial is testingTrial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced ProstatitisWho this might be right forProstate Adenocarcinoma University of Utah 10